Skip to main content
Sean Fogler, MD, Preventive Medicine, Philadelphia, PA

SeanGFoglerMD(He/Him)

Preventive Medicine Philadelphia, PA

Public Health & General Preventive Medicine

Co-founder @ Elevyst

Dr. Fogler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Fogler's full profile

Already have an account?

Education & Training

  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalResidency, Anesthesiology, 2003 - 2006
  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalInternship, Internal Medicine, 2002 - 2003
  • Albert Einstein Medical Center
    Albert Einstein Medical CenterInternship, Transitional Year, 2000 - 2000
  • Ross University School of Medicine
    Ross University School of MedicineClass of 2000

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2008 - 2019
  • NJ State Medical License
    NJ State Medical License 2007 - 2017
  • PA State Medical License
    PA State Medical License 2005 - 2016

Publications & Presentations

Journal Articles

  • Suicide Risk Factors in U.S. College Students: Perceptions Differ in Men and Women  
    Neil Seeman, Dennis K. Reilly, Sean Fogler, Suicidology Online, 2/8/2017
  • Mental Health Promotion Through Collection of Global Opinion Data  
    Neil Seeman, Sean G. Fogler, Mary V. Seeman, Journal of Preventive Medicine and Care, 7/26/2016

Authored Content

  • Opportunities for Change: An Analysis of Drug Use and Recovery Stigma in the U.S. Healthcare SystemFebruary 2023
  • How Bad Is It, Really? Stigma Against Drug Use and Recovery in the United StatesApril 2022

Press Mentions

  • Policymakers should change course on xylazine
    Policymakers should change course on xylazineJuly 5th, 2023
  • Overdose Prevention Centers Are Tough Sell in U.S. Despite Successes
    Overdose Prevention Centers Are Tough Sell in U.S. Despite SuccessesMay 8th, 2023
  • Ending the X-Waiver Doesn't End OUD-Meds Stigma in Health Care
    Ending the X-Waiver Doesn't End OUD-Meds Stigma in Health CareMarch 1st, 2023
  • Join now to see all